Quantcast

Latest Daiichi Sankyo Company Limited Stories

2014-11-10 20:30:50

TOKYO and SAN DIEGO, Nov.

2014-10-30 20:23:31

- Committee votes 9 to 1 to recommend approval of once-daily SAVAYSA for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF) TOKYO,

2014-10-14 16:28:56

TOKYO and SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- On Friday October 10, U.S.

2014-09-02 08:31:44

Results presented during ESC Congress 2014 Clinical Trial Update Hot Line session BARCELONA, Spain, Sept.

2014-03-31 08:28:47

First patient enrolled in largest planned phase 3 study evaluating a novel oral anticoagulant in non-valvular atrial fibrillation patients undergoing electrical cardioversion PARSIPPANY, N.J.,

2014-03-24 08:27:40

- Subgroup analyses of East Asian populations from two phase 3 studies, ENGAGE AF-TIMI 48 and Hokusai-VTE, showed consistent results compared to the global study populations from these trials(1,2,3,4) TOKYO,

2014-03-19 00:22:17

TOKYO, March 19, 2014 /PRNewswire/ -- Astellas Pharma Inc.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.